User:Ron130/Books/Kinasese in Cancer

Kinases in Cancer

 * Kinases
 * Protein kinase
 * Histidine kinase
 * Tyrosine kinase


 * Receptor Tyrosine Kinase
 * Non-receptor tyrosine kinase
 * Receptor tyrosine kinase
 * Serine/threonine-specific protein kinase
 * Dual-specificity kinase
 * Protein tyrosine phosphatase
 * Autophosphorylation
 * Phosphorylation


 * Receptor Tyrosine Kinase Class
 * ErbB
 * Insulin receptor
 * Platelet-derived growth factor receptor
 * Fibroblast growth factor receptor
 * VEGF receptor
 * C-Met
 * Trk receptor
 * Ephrin receptor
 * AXL receptor tyrosine kinase
 * Leukocyte receptor tyrosine kinase
 * Angiopoietin receptor
 * Receptor tyrosine kinase-like orphan receptor
 * DDR1
 * RET proto-oncogene
 * PTK7
 * Related to receptor tyrosine kinase
 * MuSK protein


 * Receptor Tyrosine Kinases in Cancer
 * Epidermal growth factor receptor
 * HER2/neu


 * Pathways of Proliferation
 * Mitogen-activated protein kinase
 * Phosphoinositide 3-kinase
 * Phospholipase C
 * STAT protein
 * Protein kinase C


 * Receptor Tyrosine Kinase Inhibitors
 * Protein kinase inhibitor
 * EGFR inhibitors
 * Zalutumumab
 * Nimotuzumab
 * Matuzumab
 * Cetuximab
 * Panitumumab
 * Gefitinib
 * Erlotinib
 * Lapatinib
 * T790M
 * Afatinib


 * Tyrosine Kinase Inhibitors
 * Sunitinib
 * Nilotinib
 * Dasatinib
 * Bosutinib
 * Ponatinib


 * Other Inhibitors
 * Axitinib
 * Cobimetinib
 * Crizotinib
 * Cabozantinib
 * Entrectinib
 * Fostamatinib
 * Ibrutinib
 * Imatinib
 * Lenvatinib
 * Mubritinib
 * Pazopanib
 * Pegaptanib
 * Ruxolitinib
 * Sorafenib
 * SU6656
 * Vandetanib
 * Vemurafenib